1[1]Cockram CS.The epidemiology of diabetes mellitus in the Asiapacific region[J].HKMJ,2000,6(1):43.
2[2]Lebowitz HE.α-Glucosidase inhibitors as agents in the treatment of diabetes[J].Diabetes Review,1998,6(2):132.
3[3]Hoffmann J,Spengler M.Efficacy of 24-week monotherapy with acarbose,metformin or placebo in dietary-treated NIDDM patients:The Essen-Ⅱ Study[J].Am J Med,1997,103:483.
4[4]Hoffmann J,Spengler M.The Essen I Study:efficacy of 24 week monotherapy with acarbose,glibenclamide or placebo in NIDDM patients[J].Diabetes Care,1994,17(6):561.
5[5]Chiasson JL,Josse RG,Hunt JA,et al.The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus:a multicenter controlled clinical trial[J].Ann Intern Med,1994,121 (12):928.
6[6]Rosak C.The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles:additive blood glucose lowering effect and decreased hypoglycacmia[J].Diabetes Nutr Metab,2002,15(3):143.
7[7]Kelley DE,Schimel D,Bidot P,et al.Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes[J].Diabetes Care,1998,21 (12):2056.
8[8]Salman S,Salman F,Satman I,et al.Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes[J].Curr Med Res Opin,2001,16(4):296.
9[9]Laube H,Linn Th,Heyen P.The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance[J].Exp Clin Endocrinol Diabetes,1998,106:231.
10[10]Meneilly GS,Ryan EA,Radziuk J.Effect of acarbose on insulin sensitivity in elderly patients with diabetes[J].Diabetes Care,2000,23(8):1162.
